(Q40002898)

16 September 2017

title

HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia (English)

1 reference

16 September 2017

1 reference

J T Whelan

1

1 reference

16 September 2017

D L Ludwig

series ordinal

2

1 reference

16 September 2017

F E Bertrand

series ordinal

3

1 reference

16 September 2017

publication date

13 March 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

22

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1161-1169

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.57

16 September 2017

exact match

0 references

cites work

HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

The pathophysiology of HOX genes and their role in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Effects of HOX homeobox genes in blood cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Evidence that the Pim1 kinase gene is a direct target of HOXA9

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Notch1 expression in early lymphopoiesis influences B versus T lineage determination.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Estrogen-regulated conditional oncoproteins: tools to address open questions in normal myeloid cell function, normal myeloid differentiation, and the genetic basis of differentiation arrest in myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Serum-induced signal transduction determines the peripheral location of beta-actin mRNA within the cell

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Expression of HOX genes in acute leukemia cell lines with and without MLL translocations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Oncogenic transcription factors in the human acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Big babies and infant leukemia: a role for insulin-like growth factor-1?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

The insulin-like growth factor system in regulation of normal and malignant hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Type I insulin-like growth factor receptor as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

IGF-I receptor signalling in transformation and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.57

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.57

1 reference

Dimensions Publication ID

16 September 2017

1049966222

0 references

1 reference